Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 5041 AL 5055

Current Technologies Unraveling the Significance of Post-Translational Modifications (PTMs) as Crucial Players in Neurodegeneration

Zafar S, Fatima SI, Schmitz M, Zerr I.

Biomolecules. 2024 Jan 16;14(1):118. doi: 10.3390/biom14010118.

Cross Talks between CNS and CVS Diseases: An Alliance to Annihilate

Chib S, Devi S, Chalotra R, Mittal N, Singh TG, Kumar P, Singh R.

Curr Cardiol Rev. 2024;20(3):63-76. doi: 10.2174/011573403X278550240221112636.

Novel Biomaterials Based Strategies for Neurodegeneration: Recent Advancements and Future Prospects

Singh D, Nagdev S.

Curr Drug Deliv. 2024;21(8):1037-1049. doi: 10.2174/0115672018275382231215063052.

Unveiling the Potential of Phytocannabinoids: Exploring Marijuana's Lesser-Known Constituents for Neurological Disorders

Basavarajappa BS, Subbanna S.

Biomolecules. 2024 Oct 13;14(10):1296. doi: 10.3390/biom14101296.

Progress of Exosomal MicroRNAs and Traditional Chinese Medicine Monomers in Neurodegenerative Diseases

Liang J, Zhu Y, Liu S, Kuang B, Tian Z, Zhang L, Yang S, Lin M, Chen N, Liu X, Ai Q, Yang Y.

Phytother Res. 2024 Nov;38(11):5323-5349. doi: 10.1002/ptr.8322. Epub 2024 Sep 3.

Neuroinflammation in Neurodegenerative Disorders: Current Knowledge and Therapeutic Implications

Giri PM, Banerjee A, Ghosal A, Layek B.

Int J Mol Sci. 2024 Apr 3;25(7):3995. doi: 10.3390/ijms25073995.

Exosomes in Vascular/Neurological Disorders and the Road Ahead

Alzahrani FA, Riza YM, Eid TM, Almotairi R, Scherschinski L, Contreras J, Nadeem M, Perez SE, Raikwar SP, Jha RM, Preul MC, Ducruet AF, Lawton MT, Bhatia K, Akhter N, Ahmad S.

Cells. 2024 Apr 12;13(8):670. doi: 10.3390/cells13080670.

Psychiatric Manifestations of Neurological Diseases: A Narrative Review

Maristany AJ, Sa BC, Murray C, Subramaniam AB, Oldak SE.

Cureus. 2024 Jul 9;16(7):e64152. doi: 10.7759/cureus.64152. eCollection 2024 Jul.

Advances in Clinical Therapies for Huntington's Disease and the Promise of Multi-Targeted/Functional Drugs Based on Clinicaltrials.gov

Huang C, Zheng X, Yan S, Zhang Z.

Clin Pharmacol Ther. 2024 Dec;116(6):1452-1471. doi: 10.1002/cpt.3341. Epub 2024 Jun 11.

Growth Factors and Their Application in the Therapy of Hereditary Neurodegenerative Diseases

Issa S, Fayoud H, Shaimardanova A, Sufianov A, Sufianova G, Solovyeva V, Rizvanov A.

Biomedicines. 2024 Aug 20;12(8):1906. doi: 10.3390/biomedicines12081906.

Editorial: Editors showcase 2023: insights in stem cell research

Emerald BS, De Francesco F, Yamane T, Castro C, Bottai D.

Front Cell Dev Biol. 2024 May 31;12:1432127. doi: 10.3389/fcell.2024.1432127. eCollection 2024.

Association between sex and Huntington's disease: an updated review on symptomatology and prognosis of neurodegenerative disorders

Hasnain N, Arif TB, Shafaut R, Zakaria F, Fatima SZ, Haque IU.

Wien Med Wochenschr. 2024 Apr;174(5-6):87-94. doi: 10.1007/s10354-022-00941-2. Epub 2022 Jun 20.

The Role of miR-137 in Neurodegenerative Disorders

Bodai L, Borosta R, Ferencz Á, Kovács M, Zsindely N.

Int J Mol Sci. 2024 Jun 30;25(13):7229. doi: 10.3390/ijms25137229.

Microstructural Changes in the Corpus Callosum in Neurodegenerative Diseases

Albadawi EA.

Cureus. 2024 Aug 21;16(8):e67378. doi: 10.7759/cureus.67378. eCollection 2024 Aug.

GABA-transaminase: A Key Player and Potential Therapeutic Target for Neurological Disorders

Grover S, Narang RK, Singh S.

Cent Nerv Syst Agents Med Chem. 2024;24(1):57-67. doi: 10.2174/0118715249267700231116053516.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias